Literature DB >> 9230162

Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors.

W S Aronow1, C Ahn, I Kronzon.   

Abstract

At 32-month follow-up of older patients with prior myocardial infarction, congestive heart failure, and a left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors, and also with digoxin if atrial fibrillation was present, propranolol caused a 35% significant reduction in total mortality and a 37% significant decrease in total mortality plus nonfatal myocardial infarction compared with no propranolol. At 1-year follow-up, propranolol caused a significantly greater increase in left ventricular ejection fraction (6%) and a significantly greater reduction in left ventricular mass (34 g) than did no propranolol (2% and 20 g, respectively).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9230162     DOI: 10.1016/s0002-9149(97)00320-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  57 in total

Review 1.  Heart failure: Part II.

Authors:  M S Wilkes; H Middlekauff; J R Hoffman
Journal:  West J Med       Date:  1999-06

2.  The evidence for beta blockers in heart failure.

Authors:  J G Cleland; J McGowan; A Clark; N Freemantle
Journal:  BMJ       Date:  1999-03-27

3.  Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?

Authors:  Melissa H Kong; Linda K Shaw; Christopher O'Connor; Robert M Califf; Michael A Blazing; Sana M Al-Khatib
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

Review 4.  Novel paradigms in the therapeutic management of heart failure with preserved ejection fraction: clinical perspectives.

Authors:  Fayez El Shear
Journal:  Am J Cardiovasc Dis       Date:  2019-10-15

Review 5.  The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

Authors:  Karen Hogg; John McMurray
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

Review 6.  Heart failure overview.

Authors:  Dennis V Cokkinos; Basil S Lewis
Journal:  Heart Fail Rev       Date:  2006-06       Impact factor: 4.214

Review 7.  Treating hypertension in older adults: safety considerations.

Authors:  Wilbert S Aronow
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 8.  Office management of patients with diastolic heart failure.

Authors:  Katina Tzanetos; Derek Leong; Robert C Wu
Journal:  CMAJ       Date:  2009-03-03       Impact factor: 8.262

9.  Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.

Authors:  Shijun Li; Xiaoying Li
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-19

Review 10.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.